(Q37998607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

What changes in inflammatory bowel disease management can be implemented today? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

27 January 2020

main subject

0 references

author

Fernando Gomollón

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

5

Stephen Hanauer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1

Edouard Louis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

6

Ailsa Hart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Daniel C Baumgart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Subrata Ghosh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Peter Irving

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

1 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

Journal of Crohn's and Colitis

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

6 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

S260-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Can calprotectin predict relapse risk in inflammatory bowel disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Fecal calprotectin: assessment of a rapid test

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Intestinal cancer risk and mortality in patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Clinical pattern of corticosteroid dependent Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Predictors of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Predictors of severe Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Infliximab, azathioprine, or combination therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Viral hepatitis and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Variation in care in pediatric Crohn disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

European evidence-based Consensus on the management of ulcerative colitis: Current management

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Epidemiology and natural history of inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting.

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

Role of biological therapy for inflammatory bowel disease in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1873-9946%2812%2960506-6

7 January 2021

10.1016/S1873-9946(12)60506-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22463933%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference